Selected article for: "infectious disease and mortality illness"

Author: Macedo, Ana; Gonçalves, Nilza; Febra, Cláudia
Title: COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis
  • Cord-id: o04bcgli
  • Document date: 2021_3_2
  • ID: o04bcgli
    Snippet: BACKGROUND: Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Although general and local public health report deathly cases, case fatality rates are still largely unknown. Thus, we sought to evaluate the mortality of COVID-19. METHODS: We searched PubMed and EMBASE databases for articles evaluating the clinical characteristics of COVID-19 patients that included clinical outcomes, between December 2020 and 24 April, 2020. Two authors performed an in
    Document: BACKGROUND: Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Although general and local public health report deathly cases, case fatality rates are still largely unknown. Thus, we sought to evaluate the mortality of COVID-19. METHODS: We searched PubMed and EMBASE databases for articles evaluating the clinical characteristics of COVID-19 patients that included clinical outcomes, between December 2020 and 24 April, 2020. Two authors performed an independent selection using predefined terms of search. RESULTS: We retrieved 33 studies with a total of 13,398 patients with COVID-19 diagnosis. The mortality rate of the COVID‐19 patients was 17.1% (95%CI 12.7; 22.7, I(2)=96.9%). For general patients admitted to the hospital (excluding critical care-only studies) the mortality rate of the COVID‐19 was 11.5% (95%CI 7.7; 16.9, I(2)=96.7%). Among critical illness studies (n=7) we found a 40.5% mortality (95%CI 31.2; 50.6, I(2)=91.8%). CONCLUSION: High COVID-19 mortality among general admitted patients and critical care cases should guide resources allocations and economic burden calculations during the pandemics.

    Search related documents:
    Co phrase search for related documents
    • abstract screening and additional information: 1
    • abstract screening and long follow: 1
    • abstract screening title and acute infection: 1
    • abstract screening title and additional information: 1
    • abstract title and acute infection: 1, 2, 3, 4
    • abstract title and additional article: 1
    • abstract title and additional information: 1, 2
    • abstract title and long follow: 1, 2
    • abstract title and low follow: 1
    • acute infection and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute infection and long follow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
    • acute infection and long recovery time: 1
    • acute infection and long term consequence: 1
    • acute infection and low follow: 1